4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029903
SVP & Chief Accounting Officer sold 5,841 shares at $3.95 ($23,072)
- SVP & Chief Accounting Officer acquired 10,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2022-05-15 | Grant or award | +10,950 | 176,268 | D: show line 1 in the form | ||
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2022-05-16 | Sale | −5,841 | $3.95 | $23,072 | 170,427 | D: show line 2 in the form |
| Open-market sales · 5,841 sh · avg $3.95 · $23,072 | |||||||
Loading xslF345X03/doc4.xml…